{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:17:58Z","timestamp":1762917478070},"reference-count":11,"publisher":"Japanese Circulation Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2014]]},"DOI":"10.1253\/circj.cj-13-1360","type":"journal-article","created":{"date-parts":[[2013,11,15]],"date-time":"2013-11-15T23:26:19Z","timestamp":1384557979000},"page":"61-62","source":"Crossref","is-referenced-by-count":4,"title":["Intracoronary Imaging of In-Stent Atherosclerosis by Coronary Angioscopy and Optical Coherence Tomography"],"prefix":"10.1253","volume":"78","author":[{"given":"Yasunori","family":"Ueda","sequence":"first","affiliation":[{"name":"Cardiovascular Division, Osaka Police Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","unstructured":" 1. Kandzari DE, Mauri L, Popma JJ, Turco MA, Gurbel PA, Fitzgerald PJ, et al. Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents: 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions). JACC Cardiovasc Interv 2011; 4: 543–550."},{"key":"2","doi-asserted-by":"crossref","unstructured":" 2. Holmes DR Jr, Leon MB, Moses JW, Popma JJ, Cutlip D, Fitzgerald PJ, et al. Analysis of 1-year clinical outcomes in the SIRIUS trial: A randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis. Circulation 2004; 109: 634–640.","DOI":"10.1161\/01.CIR.0000112572.57794.22"},{"key":"3","doi-asserted-by":"crossref","unstructured":" 3. Weisz G, Leon MB, Holmes DR Jr, Kereiakes DJ, Popma JJ, Teirstein PS, et al. Five-year follow-up after sirolimus-eluting stent implantation results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) Trial. J Am Coll Cardiol 2009; 53: 1488–1497.","DOI":"10.1016\/j.jacc.2009.01.050"},{"key":"4","doi-asserted-by":"crossref","unstructured":" 4. Stone GW, Ellis SG, Cox DA, Hermiller J, O’Shaughnessy C, Mann JT, et al. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: The TAXUS-IV trial. Circulation 2004; 109: 1942–1947.","DOI":"10.1161\/01.CIR.0000127110.49192.72"},{"key":"5","unstructured":" 5. Ellis SG, Stone GW, Cox DA, Hermiller J, O’Shaughnessy C, Mann T, et al. Long-term safety and efficacy with paclitaxel-eluting stents: 5-year final results of the TAXUS IV clinical trial (TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent). J Am Coll Cardiol Interv 2009; 2: 1248–1259."},{"key":"6","doi-asserted-by":"crossref","unstructured":" 6. Fajadet J, Wijns W, Laarman GJ, Kuck KH, Ormiston J, Münzel T, et al. Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: Clinical and angiographic results of the ENDEAVOR II trial. Circulation 2006; 114: 798–806.","DOI":"10.1161\/CIRCULATIONAHA.105.591206"},{"key":"7","doi-asserted-by":"crossref","unstructured":" 7. Fajadet J, Wijns W, Laarman GJ, Kuck KH, Ormiston J, Baldus S, et al. Long-term follow-up of the randomised controlled trial to evaluate the safety and efficacy of the zotarolimus-eluting driver coronary stent in de novo native coronary artery lesions: Five year outcomes in the ENDEAVOR II study. EuroIntervention 2010; 6: 562–567.","DOI":"10.4244\/EIJV6I5A95"},{"key":"8","doi-asserted-by":"crossref","unstructured":" 8. Stone GW, Midei M, Newman W, Sanz M, Hermiller JB, Williams J, et al. Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: A randomized trial. JAMA 2008; 299: 1903–1913.","DOI":"10.1001\/jama.299.16.1903"},{"key":"9","doi-asserted-by":"crossref","unstructured":" 9. Ishihara T, Awata M, Sera F, Fujita M, Watanabe T, Iida O, et al. Arterial repair 4 months after zotarolimus-eluting stent implantation observed on angioscopy. Circ J 2013; 77: 1186–1192.","DOI":"10.1253\/circj.CJ-12-1369"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kubo S, Kadota K, Ozaki M, Ichinohe T, Eguchi H, Miyake K, et al. Difference in clinical and angiographic characteristics of very late stent thrombosis between drug-eluting and bare-metal stent implantations. Circ J 2013; 77: 1453–1460.","DOI":"10.1253\/circj.CJ-12-1314"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Inoue T, Shinke T, Otake H, Nakagawa M, Hariki H, Osue T, et al. Neoatherosclerosis and mural thrombus detection after sirolimus-eluting stent implantation: Comparison of angioscopy and optical coherence tomography assessment for color-based tissue characterization. Circ J 2014; 78: 92–100.","DOI":"10.1253\/circj.CJ-13-0374"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/78\/1\/78_CJ-13-1360\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T04:12:38Z","timestamp":1616645558000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/78\/1\/78_CJ-13-1360\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-13-1360","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}